News

This expansion is one of the series of projects that Albemarle is undertaking to meet the growing demand for its metallocene/single site finished catalyst business. A separate production

The approval will allow the company to initiate the commercial manufacturing and packaging of the product for its sales. The company’s marketing partner will distribute the product as

The company adds R&D and commercial scale fluid bed technology, OptiMelt hot melt extrusion, at its German facility and elevates cGMP compliance for handling of OEB class 3

Previstage GCC colorectal cancer staging test provides prognostic information based on the tumour burden measured at the molecular level in the lymph nodes, a key prognostic factor to

The OnkoMatch test is designed for solid tumor cancers such as lung, breast, colon, pancreas, thyroid and skin. The test will analyze 14 oncogenes, genes that drive cancer,

A Study to Characterise the Efficacy of Natalizumab on Disability (ASCEND) trial is a double-blind placebo-controlled study in which SPMS patients are randomised to receive either Tysabri 300

The acquisition will include blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). According to the agreement, Micromet’s Munich

The wholly owned subsidiary will provide pharmaceutical sales teams with operational and human resources (HR) support. The new business unit will expand Mission’s Northeastern US presence which also

Technoclone is a reagent specialist in thrombosis and cardiovascular diagnostics. The collaboration is believed to support Roche’s plans to develop a new line of analyzers for the central